Sodium-Glucose Cotransporter-2 Inhibition in Patients With Newly Diagnosed Atrial Fibrillation: A Nationwide Cohort Study.

Huang TC, Yap LH, Lin HW, Su PH, Liao Y, Chen CY, Lee PT, Lin SH, Li YH

Open source

DOI
10.1161/jaha.126.049649
Published
2026 Sep
Container
Journal of the American Heart Association
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1161/jaha.126.049649,
  title = {Sodium-Glucose Cotransporter-2 Inhibition in Patients With Newly Diagnosed Atrial Fibrillation: A Nationwide Cohort Study.},
  author = {Huang TC and Yap LH and Lin HW and Su PH and Liao Y and Chen CY and Lee PT and Lin SH and Li YH},
  year = {2026},
  journal = {Journal of the American Heart Association},
  doi = {10.1161/jaha.126.049649},
  url = {https://doi.org/10.1161/jaha.126.049649}
}

RIS

TY  - JOUR
TI  - Sodium-Glucose Cotransporter-2 Inhibition in Patients With Newly Diagnosed Atrial Fibrillation: A Nationwide Cohort Study.
AU  - Huang TC
AU  - Yap LH
AU  - Lin HW
AU  - Su PH
AU  - Liao Y
AU  - Chen CY
AU  - Lee PT
AU  - Lin SH
AU  - Li YH
PY  - 2026
JO  - Journal of the American Heart Association
DO  - 10.1161/jaha.126.049649
UR  - https://doi.org/10.1161/jaha.126.049649
ER  - 

APA

TC, H., LH, Y., HW, L., PH, S., Y, L., CY, C., PT, L., SH, L., & YH, L. (2026). Sodium-Glucose Cotransporter-2 Inhibition in Patients With Newly Diagnosed Atrial Fibrillation: A Nationwide Cohort Study.. Journal of the American Heart Association. https://doi.org/10.1161/jaha.126.049649

Source records